Revenio Group Oyj 2023 SR
The report highlights Revenio's commitment to eye health through innovative diagnostic solutions like the AI-assisted iCare ILLUME screening tool. In 2023, the company updated its strategy for 2024-2026, focusing on connected and predictive eye care pathways. Key achievements include calculating Group-level Scope 1 and 2 emissions for the first time and maintaining high employee engagement with a score of 3.99/5. Revenio also emphasized supply chain sustainability, requiring all strategic suppliers to undergo third-party assessments.
Company: Revenio Group Oyj
Sector: Health Care
Country: Finland
Year: 2023
Type: SR
Pages: 50
Revenio Group Oyj
Sustainability Report
The report highlights Revenio's commitment to eye health through innovative diagnostic solutions like the AI-assisted iCare ILLUME screening tool. In 2023, the company updated its strategy for 2024-2026, focusing on connected and predictive eye care pathways. Key achievements include calculating Group-level Scope 1 and 2 emissions for the first time and maintaining high employee engagement with a score of 3.99/5. Revenio also emphasized supply chain sustainability, requiring all strategic suppliers to undergo third-party assessments.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Published
Mar 12, 2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Women on Board
Women in Management
Employees